PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL

Bibliographic Details
Main Authors: Jake Shortt, Brian Poligone, Vincent Ribrag, Pier Luigi Zinzani, Dima El-Sharkawi, Jan Walewski, Anca Prica, Laksmi Wilson, Sonia Souza, Harold Keer, Jason Taylor, Enrica Marchi
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000976148.07947.e7
_version_ 1797281571857760256
author Jake Shortt
Brian Poligone
Vincent Ribrag
Pier Luigi Zinzani
Dima El-Sharkawi
Jan Walewski
Anca Prica
Laksmi Wilson
Sonia Souza
Harold Keer
Jason Taylor
Enrica Marchi
author_facet Jake Shortt
Brian Poligone
Vincent Ribrag
Pier Luigi Zinzani
Dima El-Sharkawi
Jan Walewski
Anca Prica
Laksmi Wilson
Sonia Souza
Harold Keer
Jason Taylor
Enrica Marchi
author_sort Jake Shortt
collection DOAJ
first_indexed 2024-03-07T16:59:20Z
format Article
id doaj.art-c7565cf856fb48a590bbc2729f8d6fef
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:59:20Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-c7565cf856fb48a590bbc2729f8d6fef2024-03-03T03:25:48ZengWileyHemaSphere2572-92412023-08-017e07947e710.1097/01.HS9.0000976148.07947.e7202308003-02211PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCLJake Shortt0Brian Poligone1Vincent Ribrag2Pier Luigi Zinzani3Dima El-Sharkawi4Jan Walewski5Anca Prica6Laksmi Wilson7Sonia Souza8Harold Keer9Jason Taylor10Enrica Marchi111 Monash University and Monash Health, Clayton, Victoria, Australia2 Rochester Skin Lymphoma Medical Group, PLLC, Fairport, United States3 Institute of Hematology “Seràgnoli” University of Bologna Italy, Villejuif, France4 Institute of Hematology “Seràgnoli”, University of Bologna, Bologna, Italy5 The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom6 Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland7 Princess Margaret Cancer Centre, Toronto, Ontario, Canada8 Astex Pharmaceuticals, Inc., Pleasanton, United States8 Astex Pharmaceuticals, Inc., Pleasanton, United States8 Astex Pharmaceuticals, Inc., Pleasanton, United States8 Astex Pharmaceuticals, Inc., Pleasanton, United States9 Emily Couric Clinical Cancer Center, University of Virginia, Charlottsville, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000976148.07947.e7
spellingShingle Jake Shortt
Brian Poligone
Vincent Ribrag
Pier Luigi Zinzani
Dima El-Sharkawi
Jan Walewski
Anca Prica
Laksmi Wilson
Sonia Souza
Harold Keer
Jason Taylor
Enrica Marchi
PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
HemaSphere
title PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
title_full PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
title_fullStr PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
title_full_unstemmed PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
title_short PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMINARY ACTIVITY OF TOLINAPANT IN COMBINATION WITH ORAL DECITABINE/CEDAZURIDINE AND ORAL DECITABINE/CEDAZURIDINE ALONE IN SUBJECTS WITH R/R PTCL
title_sort pb2358 phase 1 2 study of the safety pk pd and preliminary activity of tolinapant in combination with oral decitabine cedazuridine and oral decitabine cedazuridine alone in subjects with r r ptcl
url http://journals.lww.com/10.1097/01.HS9.0000976148.07947.e7
work_keys_str_mv AT jakeshortt pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT brianpoligone pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT vincentribrag pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT pierluigizinzani pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT dimaelsharkawi pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT janwalewski pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT ancaprica pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT laksmiwilson pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT soniasouza pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT haroldkeer pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT jasontaylor pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl
AT enricamarchi pb2358phase12studyofthesafetypkpdandpreliminaryactivityoftolinapantincombinationwithoraldecitabinecedazuridineandoraldecitabinecedazuridinealoneinsubjectswithrrptcl